Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wu, Qian V.
31569  Ergebnisse:
Personensuche X
?
1

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Su..:

Ho, Carrie ; Gopal, Ajay K. ; Till, Brian G....
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. e33-e39.e1 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Multi-level functional genomics reveals molecular and cellu..:

Schuster, Samantha L. ; Arora, Sonali ; Wladyka, Cynthia L....
Cell Reports.  42 (2023)  8 - p. 112840 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Pembrolizumab with R‐CHOP in previously untreated diffuse l..:

Smith, Stephen D. ; Till, Brian G. ; Shadman, Mazyar S....
British Journal of Haematology.  189 (2020)  6 - p. 1119-1126 , 2020
Link: https://doi.org/10.1111/..
 
?
4

Late Events after Treatment with CD19-Targeted Chimeric Ant..:

Cordeiro, Ana ; Bezerra, Evandro D. ; Hirayama, Alexandre V....
Biology of Blood and Marrow Transplantation.  26 (2020)  1 - p. 26-33 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Urinary cross-linked carboxyterminal telopeptide, a bone re..:

Adesina, Oyebimpe O. ; Jenkins, Isaac C. ; Wu, Qian V....
Blood Cells, Molecules, and Diseases.  80 (2020)  - p. 102369 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Ultradeep, targeted sequencing reveals distinct mutations i..:

Coffey, David G. ; Wu, Qian V. ; Towlerton, Andrea M. H....
Blood Cancer Journal.  9 (2019)  10 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
7

Phase I/II Trial of Combined Pegylated Liposomal Doxorubici..:

Chang, Amy E. ; Wu, Qian V. ; Jenkins, Isaac C....
Clinical Breast Cancer.  18 (2018)  1 - p. e143-e149 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Urinary cross-linked carboxyterminal telopeptide, a bone re..:

Adesina, Oyebimpe O ; Jenkins, Isaac C ; Wu, Qian V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185370/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
9

Outcomes Among Homeless Patients With Non–Small-Cell Lung C..:

Concannon, Kyle F ; Thayer, John H ; Wu, Qian V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489482/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Ultradeep, targeted sequencing reveals distinct mutations i..:

Coffey, David G ; Wu, Qian V ; Towlerton, Andrea M. H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768874/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
11

Anakinra for Refractory Cytokine Release Syndrome or Immune..:

Gazeau, Nicolas ; Liang, Emily C. ; Wu, Qian "Vicky"...
Transplantation and Cellular Therapy.  29 (2023)  7 - p. 430-437 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Severe cytokine release syndrome is associated with hematol..:

Juluri, Krishna R. ; Wu, Qian Vicky ; Voutsinas, Jenna...
Blood Advances.  6 (2022)  7 - p. 2055-2068 , 2022
Link: https://doi.org/10.1182/..
 
?
13

Identification and Prediction of Severe Hematologic Toxicit..:

Liang, Emily C. ; Albittar, Aya ; Portuguese, Andrew J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S180-S181 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Timing of anti–PD-L1 antibody initiation affects efficacy/t..:

Hirayama, Alexandre V. ; Kimble, Erik L. ; Wright, Jocelyn H....
Blood Advances.  8 (2024)  2 - p. 453-467 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Planned Interim Analysis of a Phase 2 Investigator-Initiate..:

Liang, Emily C. ; Albittar, Aya ; Portuguese, Andrew J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S179-S180 , 2024
Link: https://doi.org/10.1016/..
 
1-15